These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25202962)

  • 21. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases.
    Favero M; Calò LA; Schiavon F; Punzi L
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):637-48. PubMed ID: 22142744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
    Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Bartter's syndrome/Gitelman's syndrome provide a clinical model for investigating the association between calcitonin gene-related peptide and angiotensin II-mediated senescence of endothelial progenitor cells?
    Tura O; Mills NL; Hadoke PW
    J Hypertens; 2010 Oct; 28(10):2170-1; author reply 2171. PubMed ID: 20844373
    [No Abstract]   [Full Text] [Related]  

  • 24. Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection.
    Calò LA; Pagnin E; Sartori M; Semplicini A; Pessina AC
    J Hypertens; 2005 Jun; 23(6):1273-5. PubMed ID: 15894907
    [No Abstract]   [Full Text] [Related]  

  • 25. Control of vascular tone in the syndromes of Bartter and Gitelman.
    Calò L; Davis PA; Semplicini A
    Crit Rev Clin Lab Sci; 2000 Dec; 37(6):503-22. PubMed ID: 11192330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.
    Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidants and Cardiorenal Vascular Remodeling-Insights from Rare Genetic Tubulopathies: Bartter's and Gitelman's Syndromes.
    Sgarabotto L; Ravarotto V; Stefanelli LF; Cacciapuoti M; Davis PA; Nalesso F; Calò LA
    Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes.
    Pagnin E; Davis PA; Semplicini A; Calò LA
    Nephrol Dial Transplant; 2006 Aug; 21(8):2340-2. PubMed ID: 16611677
    [No Abstract]   [Full Text] [Related]  

  • 29. Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.
    Davis PA; Mussap M; Pagnin E; Bertipaglia L; Savica V; Semplicini A; Calò LA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1697-701. PubMed ID: 16574683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bartter's and Gitelman's syndromes: from gene to clinic.
    Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D
    Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
    Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
    Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyses of subjects with hypokalemic metabolic alkolosis, Gitelman's and Bartter's syndrome.
    Onem Y; Kucukardali Y; Sahan B; Atasoyu EM; Ipcioğlu O; Terekeci H; Solmazgul E; Top C; Oktenli C
    Ren Fail; 2008; 30(7):691-4. PubMed ID: 18704817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
    Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
    Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PGC1alpha-PPARdelta-HO-1 system: supporting evidence from studies in Bartter's/Gitelman's syndromes.
    Calò LA; Davis PA
    Cardiovasc Res; 2010 Jun; 86(3):535. PubMed ID: 20228397
    [No Abstract]   [Full Text] [Related]  

  • 35. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
    Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
    Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Nephrol; 2010; 23(4):472-7. PubMed ID: 20349406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bartter's and Gitelman's syndrome.
    Seyberth HW; Weber S; Kömhoff M
    Curr Opin Pediatr; 2017 Apr; 29(2):179-186. PubMed ID: 27906863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter's syndrome, a Gitelman's syndrome or both?
    Addolorato G; Ancarani F; Leggio L; Abenavoli L; de Lorenzi G; Montalto M; Staffolani E; Zannoni GF; Costanzi S; Gasbarrini G
    Panminerva Med; 2006 Jun; 48(2):137-42. PubMed ID: 16953151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of Gitelman's syndrome with decreased angiotensin II-forming activity.
    Eto K; Onaka U; Tsuchihashi T; Hirano T; Nakayama M; Masutani K; Hirakata H; Urata H; Yasujima M
    Hypertens Res; 2006 Jul; 29(7):545-9. PubMed ID: 17044667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.
    Calò LA; Davis PA; Palatini P; Semplicini A; Pessina AC
    J Hum Hypertens; 2007 Nov; 21(11):904-6. PubMed ID: 17495949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.